Published in Pharmacol Rev on June 01, 2002
Tachykinin-expressing neurons control male-specific aggressive arousal in Drosophila. Cell (2014) 1.89
G protein-coupled receptors: in silico drug discovery in 3D. Proc Natl Acad Sci U S A (2004) 1.43
Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist. Nucleic Acids Res (2005) 1.17
Cellular and molecular mechanisms in environmental and occupational inhalation toxicology. GMS Curr Top Otorhinolaryngol Head Neck Surg (2004) 1.16
Lymphatic system: a vital link between metabolic syndrome and inflammation. Ann N Y Acad Sci (2010) 1.11
A neurokinin 1 receptor antagonist decreases postoperative peritoneal adhesion formation and increases peritoneal fibrinolytic activity. Proc Natl Acad Sci U S A (2004) 1.11
Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation. Ann N Y Acad Sci (2010) 1.09
Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours. Gut (2006) 1.09
Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues. Histochem Cell Biol (2008) 1.07
Blood-brain barrier integrity and breast cancer metastasis to the brain. Patholog Res Int (2010) 1.05
HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P. J Leukoc Biol (2014) 1.04
Comparative Neuropeptidomic Analysis of Food Intake via a Multi-faceted Mass Spectrometric Approach. ACS Chem Neurosci (2010) 1.01
Natalisin, a tachykinin-like signaling system, regulates sexual activity and fecundity in insects. Proc Natl Acad Sci U S A (2013) 1.01
On the role of skin in the regulation of local and systemic steroidogenic activities. Steroids (2015) 1.01
A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults. PLoS One (2011) 1.00
The first gene-encoded amphibian neurotoxin. J Biol Chem (2009) 0.99
Synaptic transmission at functionally identified synapses in the enteric nervous system: roles for both ionotropic and metabotropic receptors. Curr Neuropharmacol (2007) 0.97
Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism. J Biol Chem (2009) 0.95
Discovery of defense- and neuropeptides in social ants by genome-mining. PLoS One (2012) 0.93
Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists. Brain Res (2008) 0.93
Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation. Blood (2007) 0.92
Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway. Br J Pharmacol (2005) 0.91
Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc Natl Acad Sci U S A (2003) 0.91
Substance P activates both contractile and inflammatory pathways in lymphatics through the neurokinin receptors NK1R and NK3R. Microcirculation (2011) 0.88
Substance P as a novel anti-obesity target. Gastroenterology (2008) 0.87
Discovery and functional study of a novel crustacean tachykinin neuropeptide. ACS Chem Neurosci (2011) 0.87
A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages. Br J Pharmacol (2008) 0.87
Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury. Neurotherapeutics (2010) 0.86
Translocation of Bax and Bid to mitochondria, endoplasmic reticulum and nuclear envelope: possible control points in apoptosis. J Mol Histol (2004) 0.86
Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer. J Cancer Res Clin Oncol (2013) 0.86
Transcriptomic analysis of neuropeptides and peptide hormones in the barnacle Balanus amphitrite: evidence of roles in larval settlement. PLoS One (2012) 0.86
Transcriptomic identification of starfish neuropeptide precursors yields new insights into neuropeptide evolution. Open Biol (2016) 0.84
Staphylococcal enterotoxin B causes proliferation of sensory C-fibers and subsequent enhancement of neurogenic inflammation in rat skin. J Infect Dis (2011) 0.84
The gene expression profile of peripheral blood mononuclear cells from EV71-infected rhesus infants and the significance in viral pathogenesis. PLoS One (2014) 0.84
Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils. Behav Pharmacol (2009) 0.84
Neuropeptide substance P and the immune response. Cell Mol Life Sci (2016) 0.84
Increase in hemokinin-1 mRNA in the spinal cord during the early phase of a neuropathic pain state. Br J Pharmacol (2008) 0.82
The activation of transient receptor potential vanilloid receptor subtype 1 by capsaicin without extracellular Ca2+ is involved in the mechanism of distinct substance P release in cultured rat dorsal root ganglion neurons. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.82
The role of substance p in ischaemic brain injury. Brain Sci (2013) 0.81
Inflammation in acute CNS injury: a focus on the role of substance P. Br J Pharmacol (2015) 0.81
Significance of Conversation between Mast Cells and Nerves. Allergy Asthma Clin Immunol (2005) 0.81
Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system. Int J Inflam (2013) 0.81
Association of genetic variants in tachykinins pathway genes with colorectal cancer risk. Int J Colorectal Dis (2012) 0.81
Effects of a skin neuropeptide (substance p) on cutaneous microflora. PLoS One (2013) 0.81
The pathophysiology of brain swelling associated with subdural hemorrhage: the role of the trigeminovascular system. Childs Nerv Syst (2012) 0.81
Similar effects of substance P on learning and memory function between hippocampus and striatal marginal division. Neural Regen Res (2014) 0.80
Sensory innervation of normal and hypospadiac prepuce: possible implications in hypospadiology. Pediatr Surg Int (2004) 0.80
Hemokinin-1(4-11)-induced analgesia selectively up-regulates δ-opioid receptor expression in mice. PLoS One (2014) 0.80
Role of substance P in viral myocarditis in mice. Heart Vessels (2010) 0.79
G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer? Toxins (Basel) (2015) 0.79
On the split personality of penultimate proline. J Am Soc Mass Spectrom (2014) 0.79
Dermaseptins and magainins: antimicrobial peptides from frogs' skin-new sources for a promising spermicides microbicides-a mini review. J Biomed Biotechnol (2009) 0.79
Neurokinin B-related Peptide Suppresses the Expression of GnRH I, Kiss2 and tac3 in the Brain of Mature Female Nile tilapia Oreochromis niloticus. Balsaenggwa Saengsig (2016) 0.79
Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor. J Neurovirol (2013) 0.78
The endocrine stress response is linked to one specific locus on chromosome 3 in a mouse model based on extremes in trait anxiety. BMC Genomics (2012) 0.78
TACR3 mutations disrupt NK3R function through distinct mechanisms in GnRH-deficient patients. FASEB J (2013) 0.78
Systemic administration of substance P recovers beta amyloid-induced cognitive deficits in rat: involvement of Kv potassium channels. PLoS One (2013) 0.78
Effects of sensory denervation by neonatal capsaicin administration on experimental pancreatitis induced by dibutyltin dichloride. Med Mol Morphol (2007) 0.78
Effect of Substance P in Staphylococcus aureus and Staphylococcus epidermidis Virulence: Implication for Skin Homeostasis. Front Microbiol (2016) 0.78
The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders. Front Cell Neurosci (2017) 0.77
New mechanisms and perspectives in nicotine withdrawal. Neuropharmacology (2014) 0.77
GPCR Heterodimerization in the Reproductive System: Functional Regulation and Implication for Biodiversity. Front Endocrinol (Lausanne) (2013) 0.77
Tachykinins stimulate a subset of mouse taste cells. PLoS One (2012) 0.77
Mechanisms underlying the inhibitory effects of tachykinin receptor antagonists on eosinophil recruitment in an allergic pleurisy model in mice. Br J Pharmacol (2003) 0.76
A contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis. Oncotarget (2015) 0.76
Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. J Neuroinflammation (2016) 0.76
Neurokinin-2 receptor polymorphism predicts lymph node metastasis in colorectal cancer patients. Oncol Lett (2015) 0.76
Membrane-Induced Structure of Scyliorhinin I: A Dual NK1/NK2 Agonist. Biophys J (2005) 0.76
Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders. Front Neurosci (2014) 0.76
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system. Clin Exp Immunol (2016) 0.76
Substance P and Calcitonin Gene-Related Peptide: Key Regulators of Cutaneous Microbiota Homeostasis. Front Endocrinol (Lausanne) (2017) 0.75
Prokinetic and laxative effects of the crude methanolic extract of Viola betonicifolia whole plant in rodents. BMC Complement Altern Med (2013) 0.75
Substance P-mediated chemokine production promotes monocyte migration. J Leukoc Biol (2016) 0.75
Role of neurokinin type 1 receptor in nociception at the periphery and the spinal level in the rat. Spinal Cord (2015) 0.75
Transcriptional landscapes at the intersection of neuronal apoptosis and substance P-induced survival: exploring pathways and drug targets. Cell Death Discov (2016) 0.75
Amygdala-Dependent Molecular Mechanisms of the Tac2 Pathway in Fear Learning. Neuropsychopharmacology (2016) 0.75
Substance P/Neurokinin 1 and Trigeminal System: A Possible Link to the Pathogenesis in Sudden Perinatal Deaths. Front Neurol (2017) 0.75
Baltikinin: A New Myotropic Tryptophyllin-3 Peptide Isolated from the Skin Secretion of the Purple-Sided Leaf Frog, Phyllomedusa baltea. Toxins (Basel) (2016) 0.75
Specificity of a Vibrio vulnificus aminopeptidase toward kinins and other peptidyl substrates. J Bacteriol (2006) 0.75
Development of the Neurochemical Architecture of the Central Complex. Front Behav Neurosci (2016) 0.75
Cod CGRP and tachykinins in coeliac artery innervation of the Atlantic cod, Gadus morhua: presence and vasoactivity. Fish Physiol Biochem (2008) 0.75
Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease. World J Gastroenterol (2017) 0.75
Neurochemistry of the Anterior Thalamic Nuclei. Mol Neurobiol (2016) 0.75
Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. Eur J Biochem (2002) 1.99
Dmt and opioid peptides: a potent alliance. Biopolymers (2003) 1.40
Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties. J Med Chem (2002) 1.40
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc Natl Acad Sci U S A (2009) 1.24
Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore. J Med Chem (2002) 1.23
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br J Pharmacol (2002) 1.14
Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation. J Biol Chem (2006) 1.13
Interaction of sweet proteins with their receptor. A conformational study of peptides corresponding to loops of brazzein, monellin and thaumatin. Eur J Biochem (2004) 1.11
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor. Med Res Rev (2010) 1.09
Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists. J Med Chem (2009) 1.08
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. J Neurosci (2005) 1.06
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides (2007) 1.05
In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S. J Pharmacol Exp Ther (2008) 1.05
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors. Eur J Pharmacol (2004) 1.04
Evidence of central and peripheral sensitization in a rat model of narcotic bowel-like syndrome. Gastroenterology (2010) 1.04
Solution structure of amyloid beta-peptide (25-35) in different media. J Med Chem (2004) 1.04
6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides. J Med Chem (2006) 1.02
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. CNS Drug Rev (2005) 1.01
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores. J Med Chem (2006) 1.00
Triazine compounds as antagonists at Bv8-prokineticin receptors. J Med Chem (2008) 0.99
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore. J Med Chem (2006) 0.97
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. Peptides (2010) 0.97
Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic. J Med Chem (2004) 0.96
Evolution of the Bifunctional Lead μ Agonist / δ Antagonist Containing the Dmt-Tic Opioid Pharmacophore. ACS Chem Neurosci (2010) 0.96
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism. J Med Chem (2004) 0.96
Activation of DOR attenuates anoxic K+ derangement via inhibition of Na+ entry in mouse cortex. Cereb Cortex (2008) 0.96
Synthesis and biological activity of human neuropeptide S analogues modified in position 2. J Med Chem (2008) 0.95
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior. J Neurosci (2004) 0.95
A new ligand for the urotensin II receptor. Br J Pharmacol (2002) 0.95
Interaction of calmodulin with the phosphofructokinase target sequence. FEBS Lett (2004) 0.95
Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor. J Med Chem (2007) 0.94
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor. Peptides (2007) 0.93
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. J Med Chem (2009) 0.92
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. Eur J Pharmacol (2009) 0.92
Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1). J Med Chem (2005) 0.91
Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats. Peptides (2002) 0.90
Conformationally constrained opioid ligands: the Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffold. Bioorg Med Chem Lett (2008) 0.89
Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesia. J Med Chem (2003) 0.89
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803). Br J Pharmacol (2006) 0.89
Synthesis and opioid activity of N,N-dimethyl-Dmt-Tic-NH-CH(R)-R' analogues: acquisition of potent delta antagonism. Bioorg Med Chem (2003) 0.89
Pharmacological profile of nociceptin/orphanin FQ receptors. Clin Exp Pharmacol Physiol (2002) 0.89
Peripheral anti-nociceptive effect of nociceptin/orphanin FQ in inflammation and stress-induced colonic hyperalgesia in rats. Pain (2009) 0.88
Structure-activity study at positions 3 and 4 of human neuropeptide S. Bioorg Med Chem (2008) 0.88
Effect of δ-opioid receptor activation on BDNF-TrkB vs. TNF-α in the mouse cortex exposed to prolonged hypoxia. Int J Mol Sci (2013) 0.87
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist. Bioorg Med Chem (2005) 0.86
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). J Med Chem (2011) 0.86
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex. Eur J Neurosci (2004) 0.86
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. Bioorg Med Chem (2009) 0.85
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies. Peptides (2006) 0.84
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids. Bioorg Med Chem (2007) 0.84
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore. J Med Chem (2009) 0.84
Structure-activity relationship study on human urotensin II. J Pept Sci (2005) 0.84
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor. J Pharmacol Exp Ther (2004) 0.83
Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists. J Med Chem (2005) 0.83
The SH3 domain of nebulin binds selectively to type II peptides: theoretical prediction and experimental validation. J Mol Biol (2002) 0.83
New 2',6'-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligands. J Med Chem (2006) 0.83
Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic. J Med Chem (2008) 0.82
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore. Bioorg Med Chem (2007) 0.82
The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ. Chemistry (2005) 0.82
From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH. J Med Chem (2005) 0.82
Urotensin II stimulates plasma extravasation in mice via UT receptor activation. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.82
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice. Peptides (2006) 0.82
Selective delta-opioid receptor antagonist N,N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats. Addict Biol (2003) 0.81
UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor. CNS Neurosci Ther (2010) 0.81
Modeling of overloaded gradient elution of nociceptin/orphanin FQ in reversed-phase liquid chromatography. J Chromatogr A (2005) 0.81
Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study. Urology (2003) 0.80
Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds. Bioorg Med Chem Lett (2010) 0.80
Expression of NK-1 and NK-3 tachykinin receptors in pancreatic acinar cells after acute experimental pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol (2006) 0.80
Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study. Pharmacol Res (2006) 0.80
Role of 2',6'-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds. Bioorg Med Chem (2010) 0.80
Gastrointestinal effects of intracerebroventricularly injected nociceptin/orphaninFQ in rats. Peptides (2004) 0.80
Synthesis and antimicrobial activity of dermaseptin S1 analogues. Bioorg Med Chem (2008) 0.79
Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging. J Med Chem (2008) 0.79
Inhibition of the development of morphine tolerance by a potent dual mu-delta-opioid antagonist, H-Dmt-Tic-Lys-NH-CH2-Ph. Pharmacol Biochem Behav (2008) 0.79
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore. J Med Chem (2002) 0.78
Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice. Eur J Pharmacol (2009) 0.78
Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis. Pharmacol Res (2013) 0.78
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.78
Neuropeptide S inhibits stress-stimulated faecal output in the rat. Pharmacol Res (2011) 0.78
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex. Toxicol Sci (2012) 0.77
The effects of neuropeptide S on general anesthesia in rats. Anesth Analg (2011) 0.77
TLQP-21, a VGF-derived peptide, prevents ethanol-induced gastric lesions: insights into its mode of action. Neuroendocrinology (2010) 0.77
δ-Opioid receptor activation modified microRNA expression in the rat kidney under prolonged hypoxia. PLoS One (2013) 0.77
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues. Mol Divers (2012) 0.77
Optimization of peptides that target human thymidylate synthase to inhibit ovarian cancer cell growth. J Med Chem (2014) 0.77
Nociceptin/Orphanin FQ(1-13)NH2 analogues modified in the Phe1-Gly2 peptide bond. Bioorg Med Chem Lett (2003) 0.76
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands. J Med Chem (2005) 0.76
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.76
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic. Eur J Med Chem (2010) 0.76
Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitro. Br J Pharmacol (2003) 0.76
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain. J Nucl Med (2011) 0.75
Solution structure of nociceptin peptides. J Pept Sci (2002) 0.75
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. Peptides (2009) 0.75
In vitro activity of dermaseptin S1 derivatives against genital pathogens. APMIS (2010) 0.75
Immunocytochemical distribution of NK-1 and NK-3 tachykinin receptors in isolated pancreatic acini of guinea pigs and rats. Peptides (2005) 0.75
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis. J Med Chem (2014) 0.75
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11). Peptides (2007) 0.75
Peptides and proteins in a confined environment: NMR spectra at natural isotopic abundance. J Pept Sci (2007) 0.75
The hypothalamus-pituitary-adrenal axis does not influence the protective effects of nociceptin/orphanin FQ on the rat gastric mucosa. Regul Pept (2008) 0.75